Regulatory strategiesThat accelerate safe MedTech innovation
Secure regulatory approval right first time.
Accelerate market entry. Protect funding timelines.
regulatory landscape
resource-constrained teams
approval & post-market scale-up
Guided by experts who have engineered novel medical devices, Led CE marking assessments, and worked in high-stakes clinical environments.
across EU and UK pathways
EU and UK market access
We support MedTech companies developing innovative and high-risk devices, where regulatory strategy is central to patient safety and commercial success.
Startups preparing for first approval
Scale-ups managing market expansion
Academic spinouts moving from research to regulated product
We help you identify and resolve the problems that lead to delays, rework, and failed submissions.
Unclear regulatory pathway
Investor pressure on timelines
Risk of delays or failed submissions
We define a clear, straight and structured strategy
We align regulatory and commercial milestones
We strengthen your evidence and submission strategy
Move forward with confidence
Stay on track and protect funding
Improve approval outcomes
Are you on track for MDR approval?
Take our Regulatory Readiness Assessment and benchmark your strategy against Notified Body and investor expectations.
Get a clear view of your risks, gaps, and next steps.
Understand risks that could delay approval
Identify gaps in your regulatory strategy
Get actionable insights
Free. Takes 3–5 minutes. Instant tailored report.
Regulatory expertise informed by how conformity assessment are done
MedStride brings deep understanding of global regulatory frameworks, combined with hands-on MedTech engineering, clinical and usability insights. We understand how regulatory decisions are assessed, where delays occur, and what it takes to get innovative MedTech approved
Notified Body Insight
We understand how decisions are made at source, not just how to prepare for them.
Where Submissions Fail
We identify the exact points where delays and rework occur and prevent them early.
High-Risk Device Expertise
We specialise in high-risk and innovative devices where regulatory strategy is critical.
Regulatory support that keeps your project on track, from strategy through to approval and post-market
A strategic partner at every stage of your product's life cycle
We bring structure and clarity to complex projects, operating as an extension of your team across strategy, evidence development, and operations.
01 — Strategy
Define and de-risk critical decisions early
We establish the right regulatory pathway from the outset, ensuring your strategy is aligned with your device, timelines, and commercial objectives.
02 — Evidence
Build evidence that meets regulatory expectations
We structure your clinical and technical documentation to align with Notified Body expectations, reducing compliance risk, questions, or rework.
03 — Leadership & Execution
Guide execution and maintain momentum
We embed into your team to support delivery, guide key decisions, and ensure your program stays aligned through submission and approval.
Trusted by founders and leadership teams navigating complex regulatory decisions
"MedStride brought the expertise and flexibility our team really needed. We had a strong product but felt overwhelmed by regulatory decisions. They explained the requirements, mapped potential scenarios and helped us focus on the right priorities."
CEO & Founder, Stealth MedTech Startup"Dr Rahmani identified critical gaps in our MDR plan early and helped us build a defensible submission. His Notified Body insight was exceptionally valuable for our class III device."
Clinical Entrepreneur, Stealth MedTech StartupWe work with MedTech startups and scaling manufacturers developing moderate to high-risk devices, particularly those preparing for or navigating EU MDR and UKCA approval.
Most of our clients are founders and leadership teams operating under time, funding, or regulatory pressure.
We bring insider perspective from working within a Notified Body environment, combined with hands-on industry experience.
This allows us to go beyond documentation support and provide strategic regulatory guidance that helps you avoid delays, reduce risk, and make better decisions earlier.
Yes. In fact, this is where we often add the most value.
Early regulatory strategy decisions have a direct impact on timelines, costs, and approval success. We help ensure your approach is aligned from the outset.
Yes.
We often support teams who are:
- Experiencing delays
- Facing Notified Body feedback
- Reworking technical documentation
- Reassessing their regulatory strategy
We help diagnose the issue and put a clear path forward in place.
Yes.
We support companies developing software and AI-enabled medical devices, including navigating the overlap between MDR requirements and emerging AI regulatory frameworks.
Fractional regulatory leadership means embedding senior regulatory expertise into your team on a flexible basis.
Instead of hiring a full-time Head of Regulatory, you gain access to experienced strategic guidance when you need it, helping you:
- Define regulatory strategy
- Interface with Notified Bodies
- Guide internal teams
- De-risk key decisions
We usually begin with a diagnostic step to understand your current position, risks, and objectives.
This may be through:
- A structured assessment
- A focused strategy call
- Or review of key documentation
From there, we define a clear and practical path forward.
Many teams believe they are on the right path until late-stage issues arise.
Our role is to provide an independent, expert view to identify:
- Gaps in strategy
- Misalignment with MDR expectations
- Risks that could delay approval
This is also something you can explore through our regulatory readiness scorecard.
No consultant can guarantee approval.
What we do is significantly improve your likelihood of success by ensuring your strategy, documentation, and approach are aligned with regulatory expectations from the outset.
Our level of involvement depends on your needs.
We can:
- Provide high-level strategic input
- Support specific regulatory workstreams
- Or act as an embedded regulatory lead within your team
We primarily support moderate to high-risk medical devices, including complex and innovative technologies where regulatory strategy is critical.
A good first step is to understand where you currently stand.
You can:
- Take our regulatory readiness scorecard
- Or get in touch to discuss your situation
From there, we can advise whether and how we can help.